Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023265

Chief Medical Officer bought 5,000 shares at $5.06 ($25,311)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Clark David J Chief Medical Officer 2019-09-06 Purchase +5,000 $5.06 $25,311 17,878 D: show line 1 in the form
Open-market purchases · 5,000 sh · avg $5.06 · $25,311
Loading xslF345X03/doc4.xml…